Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary

August 9, 2023

New York Stock Exchange US Materials Chemicals earnings 30 min

Earnings Call Speaker Segments

Larry Busnardo

executive
#1

Thanks, Dave. Morning, everyone. We’re glad you could join Flotek’s Q2 2023 earnings conference call. With me today are Ryan Ezell, our Chief Executive Officer, and Bond Clement, our Chief Financial Officer. During this call, we’ll begin with prepared comments about the business and our results for the quarter. After that, we’ll open the lines so you can ask any questions you may have. We released our earnings announcement for Q2 2023 yesterday afternoon, and it’s posted in the investor relations area of Flotek’s website. We’ve also put up a refreshed, more robust corporate presentation that we’ll refer to during today’s call. We’d encourage you to take some time to look it over. Also, this call is being webcast, and a replay will be made available on our website soon after the call ends. Please keep in mind that anything we say today about projections or what we expect for future events counts as forward-looking statements. Forward-looking statements involve a range of risks and uncertainties, many of which we can’t control. Those risks and uncertainties could lead actual results to differ materially from what we currently expect. We advise listeners to review our earnings release and the risk factors covered in our SEC filings. Also, please see the reconciliations included in our earnings release, since management may talk about non-GAAP financial metrics on this call. With that, I’ll hand the call over to Ryan Ezell, Chief Executive Officer. Ryan?

Ryan Ezell

executive
#2

Thank you, Larry. Good morning, everyone. We're grateful that all of you are interested in Flotek and could be with us today while we go over the operational and financial results for our second quarter of 2023. As nearly all of you are aware, this marks my debut earnings call in the CEO seat at Flotek, and I feel privileged to hold this position during such a transformative period for the organization. I want to pause briefly to express my thanks to Harsha Agadi for the time he served as Interim CEO, and to congratulate him as he comes back to Flotek's Board of Directors in the role of Chairman. Now, moving on to the quarter, what we achieved in the second quarter shows the substantial strides we've taken toward strengthening Flotek's business fundamentals while carrying out our corporate strategy; that has produced, in turn, a notable rise in profitability across Flotek's unique and complementary business segments. On top of that, I anticipate that the organization will keep following its upward path of improving results through the rest of the year. Let's be clear, our work is intensely concentrated on growing revenue, expanding market share, and capturing cost efficiency gains through our differentiated technologies across both chemistry and data analytics solution platforms. Each of them offers an undeniable value proposition that maximizes our customers' value chain while delivering a meaningful ROI for our shareholders. With that said, I'd like to move to slide 7 and discuss the highlights of our second quarter. The overall results please me, since we delivered a 72% rise in total revenues compared with the second quarter of 2022; we also saw strong growth in gross profit, which more than doubled versus the first quarter of 2023. We posted positive adjusted gross profit for a second quarter in a row and demonstrated an improvement in adjusted EBITDA for an eighth straight quarter, and we are now forecasting positive adjusted EBITDA before the year ends. Revenues from our transactional chemistry business rose 68% compared with the first quarter of 2023. That reflects our customer base expanding quickly and continuing adoption of our Prescriptive Chemistry Management business model, which has shown 171% growth in applications of our proprietary Complex nano Fluid versus the second quarter of 2022. Our data analytics revenues keep building momentum, since revenues for the first half of 2023 have roughly matched what we recorded across all of 2022. These better results mirror the positive, impactful changes we've accomplished within a very brief span of time. Above all, every one of these milestones came about alongside 0 recordable and lost time incidences in the field of operations. I want to thank each of our employees for their dedication to safety and service quality in delivering these outstanding results; now, as slide 12 highlights, Flotek keeps setting itself apart as the collaborative partner of choice in the industry for sustainable, optimized chemistry and data solutions serving E&P operators and oil field service providers. What genuinely sets Flotek apart from its peers is our global footprint spanning over 15 countries, covering all major U.S. shale basins, together with our deep expertise, delivering sustainable chemical and data solutions across more than 20,000 completed wells worldwide. One recent illustration of how we stand apart is that Aramco has given the green light to Flotek's slickwater system. At present, in Saudi Arabia, only two hydraulic fracturing systems are approved and in use, and ours is one of them. This edge over competitors stems not just from having superior technology, but also from running efficiently, cutting expenses and lessening environmental effects, all while boosting how well our customers' assets perform. There's another key piece of Flotek's competitive edge: our producer customers tell us they get better well output when they use our chemistry applications. On slide 16, you can see a comparison of production from wells in the Permian Basin that use Flotek's Prescriptive Chemistry Management against wells that don't use Flotek. The chart shows that wells using our Prescriptive Chemistry Management saw a 26% average performance gain — that's a cumulative addition of 75,000 barrels of oil equivalent over 24 months — relative to wells lacking Flotek chemistry. That underscores just how effective Flotek's chemistry solutions are at improving asset performance. Although this is just a snapshot of results from the Permian Basin, we've observed comparable outcomes across every other shale basin. Moving on to slide 17, we keep applying our know-how to both new and established market verticals. This puts Flotek in a position to take advantage of our proprietary patents, technological progress, and collaborative partnerships that already have demonstrated commercial uses in other industry subsectors, opening up major future growth prospects while broadening our revenue mix. We expect demand for our sustainable chemistry solutions to keep growing, creating chances in additional international and domestic market verticals, including industrial, geothermal, agricultural, solar, and hydrogen. Now let's look at slide 18. As we mentioned last quarter, our data analytics segment got the first prototype of the next generation spectrometer for field testing and validation, and you can see it on the slide. The proprietary Verax analyzer is able to check hydrocarbon quality in real time, unlike traditional sampling methods. Once it's up and running, this next generation Verax unit will mark a huge leap forward in our manufacturing capabilities and operational costs for the data analytics segment, as we make the crucial shift toward a more subscription-based service model. As laid out on slide 19, there are wide-ranging industry applications across the upstream, midstream, and downstream segments. We think the next generation model will be scalable enough to push further into what we expect will be an enormous upstream market opportunity. At this point, I'd like to hand the call over to Bond to go through the detailed financial highlights.

Bond Clement

executive
#3

Thank you, Ryan; it's wonderful to be here with everyone this morning. Let me begin by expressing that all of us at Flotek are incredibly enthusiastic about the numbers we shared yesterday. In my view, yesterday's announcement addresses numerous items that we've been striving toward and that investors have been eager to witness. If we return to slide seven briefly, we recorded enormous improvement in gross profit; we achieved robust revenue contribution from our transactional chemistry business. We gave clarity around hitting positive adjusted EBITDA prior to the close of the year, and we brought you up to date on substantial advancement toward obtaining an ABL. The accomplishments and performance we delivered through the first half of the year leave us confident about meeting our full year guidance, which anticipates total revenues ranging from $210 million to $230 million, representing over 60% growth in annual revenue compared with last year, along with an 8%-10% adjusted gross profit margin. Reaching the midpoint of both these metrics would amount to an almost $22 million yearly gain in adjusted gross margin relative to what we delivered last year. Clearly, that's quite a transformation and something we take pride in. Now looking at the income statement, on a sequential basis, revenues climbed 5% despite a widely reported decline in upstream land activity throughout the quarter. As Ryan mentioned, our transactional chemistry revenues increased by over $6 million in the quarter and ultimately accounted for more than 30% of total revenue, rising from just 19% during the first quarter. That's a major achievement since it delivers diversity in revenue sources by lowering our customer concentration. Now on slide 10, our second quarter gross profit rose 108% compared with the first quarter. Our adjusted gross profit, which strips out certain non-cash costs, saw a 92% increase from the first quarter. Gross profit margin and adjusted gross profit margin for the quarter climbed to 8% and 10%, respectively. With two straight quarters of positive gross profit, our cumulative gross profit across the first two quarters of 2023 is tracking nearly $10 million above the cumulative gross profit for the last two quarters of the prior year. Helping drive positive margins in the quarter were $1.2 million of revenue tied to the ProFrac contract modification we told you about earlier this year, plus a 13% sequential decrease in our freight costs. This represents the second quarter in a row of double-digit freight cost reduction. In dollar terms, second quarter freight costs came in roughly $500,000 below first quarter 2023, and approximately $1.3 million below the fourth quarter of 2022. That's, that's even though revenues were 5% greater for, for, for the second quarter. Now on slide 11, second quarter adjusted EBITDA rose another 48% sequentially. As we stated in yesterday's release, we now expect to report positive adjusted EBITDA prior to the conclusion of this year. I, along with plenty of you I'd bet, can't wait for the day when we stop having to talk about how much better the negative numbers are getting. Turning to SG&A — just to remind everybody, Q1 of 2023 got a boost from a $1.1 million credit tied to non-cash stock comp, which came from the headcount reductions we carried out during that first quarter. If you set stock comp aside, SG&A for Q2 rose roughly $500,000, and that figure took in legal fees connected to settling part of our legacy litigation, plus the last of the costs from our CEO transition. Two of the three pieces of that legacy litigation are now behind us, so it's encouraging that everything could be finished before the year wraps up. Because of that, we look for G&A costs to come back down in Q3. Just a quick word on the severance expense credit this quarter — we'd already accrued some severance costs tied to the legacy litigation I just described. When that portion of the litigation settled, we could reverse the accrual in Q2. On the bottom line, we posted a small net loss this quarter, compared with $21 million of net income in Q1. That Q1 net income got help from a $26 million non-cash gain on the fair value change of our convertible notes, plus a $4.5 million gain from forgiving our PPP loan. The last tranche of those convertible notes converted in May into 63.5 million shares, so going forward we won't deal with earnings volatility from measuring the notes at fair value. On the balance sheet — with that final convertible note tranche converted to equity, our June 30 balance sheet is essentially delevered now, showing only about $300,000 in total debt. Jumping to slide 21 quickly, I'm happy to say we've made real progress toward landing an ABL facility. The simple fact that Flotek couldn't get a loan like this a year ago says a lot about how much the company's finances have improved these past few quarters. The ABL should be backed by some of our receivables, our inventory, and our blending facility in Marlow, Oklahoma; the prospective lender gave us credit approval recently, and right now we're going through the loan documents and wrapping up a few final administrative items before we close. We're thrilled that we expect to share the outcome of this process well ahead of month's end. Briefly on the NYSE sub $1 listing matter — clearly we'll be watching how the stock trades in the coming weeks. Like we've said, we'd strongly prefer to fix the deficiency on our own by capitalizing on the potential upside from the very strong financial results we announced yesterday. We also have some fresh news about where we stand on an ABL, plus our presence at the EnerCom conference that takes place next week. October 12 is the date by which we must be compliant, so there is still a window before a decision becomes necessary. Just to repeat what was said during the prior quarter: we already hold shareholder authorization to carry out a reverse split of as much as one for six, should that step be required. On the topic of our special shareholder meeting set for September 5th, the definitive proxy statement has been submitted, and voting materials ought to be arriving with shareholders. To make sure we achieve the greatest possible shareholder participation, we have brought in a proxy solicitor to run an outreach effort. Both proposals have the unanimous recommendation of our board for a favorable vote. One more reminder for everyone: when shareholders approve the June 2022 pre-funded warrants that ProFrac holds, Flotek stands to gain the chance of receiving $4.5 million in cash proceeds once those warrants get converted into shares. Clearly, that is a development that would work in favor of every shareholder. Looking at the halfway mark of the year, there is plenty we can take pride in. For the period through June, we posted an improvement of almost $10 million in adjusted gross margin along with an improvement of nearly $7 million in adjusted EBITDA, measured against the first six months of the prior year; going forward, we anticipate gross margins will keep climbing across the quarters ahead. Every chance we get, we will continue going after SG&A. Regarding those SG&A reductions, a new lease for our corporate headquarters was signed not long ago. Over the next two weeks, we anticipate finishing the relocation. Because the footprint is much smaller, the lease on our new office will deliver yearly savings exceeding $500,000 relative to the current office location that we are leaving; that brings my remarks to a close. I'll hand the call back to Ryan now for closing comments.

Ryan Ezell

executive
#4

Thank you, Bond. Moving on to slide 22. To sum up, Flotek represents an attractive investment prospect at present, since the turnaround progress achieved by streamlining operations and boosting earnings is not yet mirrored in our stock price, and I have faith in our capacity to carry out the company's strategy moving ahead. The fresh leadership group at Flotek possesses extensive sector knowledge to steer the company onward and deliver on its subsequent stage of expansion. Our business units are complementary, and we will keep pushing for revenue growth along with consistent gains in profitability, as we expect to produce more than 60% growth in yearly revenues and over $20 million in yearly gross margin gains; we hold a $2 billion backlog of upcoming revenue across the coming 10 years, backed by our long-standing ProFrac partnership. Furthermore, we foresee continued growth both domestically and abroad within our high-margin transactional chemistry and data analytics operations, as we keep capturing additional market share in each; we also keep gaining from our cost reduction efforts that lift profitability and support a shift to positive adjusted EBITDA by the close of the year. Lastly, we hold a robust balance sheet with minimal debt, which might be strengthened by extra liquidity from the proposed ABL facility that we are aiming to establish soon. We recognize that further effort is required, yet all of us are set to seize the considerable opportunities ahead as we generate value for our shareholders. We are grateful for the ongoing backing of everyone involved with our company, and we hope you feel the same enthusiasm we do about Flotek's future. Operator, we are now prepared to take questions.

Don Crist

analyst
#5

Good morning, everyone. How's everybody doing today?

Ryan Ezell

executive
#6

Good morning, Don.

Bond Clement

executive
#7

(Bond Clement): Hello, Don.

Don Crist

analyst
#8

(Don Crist): Ryan, I’d like to begin with slide 16. Clearly, this information is new to me, but regarding the 26% improvement in well performance, first, how broadly does it apply, or how many wells does it include? Second, is this actually gaining momentum for your transactional business in the Permian?

Ryan Ezell

executive
#9

(Ryan Ezell): Yes. Don, if you examine these figures, we were extremely careful in the way we conducted this analysis, and we reviewed more than 1,800 wells across the Permian Basin. Even more importantly, we established rigorous criteria for the review, including lateral length, completion design, proppant intensity, and fluid system choice, all of which we obtained from publicly available data. You are entirely right that we are beginning to observe meaningful momentum in our transactional business, fueled by the value proposition tied to our customized chemistry technologies. What makes this distinctive is that we embarked on this effort. It has somewhat been a long-term endeavor for us, since we initiated these EUR-type engagements with our customers nearly 18 months ago, and now you are truly seeing them bear fruit, as evidenced by what this data shows.

Don Crist

analyst
#10

That's really thrilling information. Then, a second inquiry regarding expenses. So, you mention that shipping and logistics prices are declining. I realize you've been addressing this issue for a good while. At what stage are we with that advancement, and do you anticipate further expense reductions ahead?

Ryan Ezell

executive
#11

When examining transportation, if we consider, for instance, our position at the close of 2022's fourth quarter compared to the present quarter, our shipping expenses decreased by roughly $1.3 million even as revenue rose by nearly $500,000. Even more significantly, between the first and second quarters, we experienced a $500,000 reduction in transportation expenses alongside growing revenue. One might begin to picture that we're achieving considerable gains in efficiency concerning our approach to extended versus brief distances and likewise for deliveries made directly in the field.

Don Crist

analyst
#12

Alright, Bond, I've got just one question for you. Since all the convertible notes have now been converted, is it possible to get a clear share count? I realize there are still warrants outstanding, but as of today, what does that clean share count look like?

Bond Clement

executive
#13

Sure. If both proposals at the special meeting are approved, there are 2 tranches of pre-funded warrants that shareholders still need to sign off on. We'll end up with a final share count of roughly 190 million shares.

Don Crist

analyst
#14

Okay, that's helpful context, everyone. Solid quarter. I'll hand it back over.

Bond Clement

executive
#15

Thank you, Don.

Ryan Ezell

executive
#16

Thanks, Don.

Richard Dearnley

analyst
#17

Morning. If I work through what you said about non-transactional business accounting for 30% of revenue, that comes to roughly $15.2 million, compared with $9.1 million in the first quarter. Is that right?

Bond Clement

executive
#18

Yes, that's right. From Q1 to Q2 it rose by roughly $6 million.

Richard Dearnley

analyst
#19

All right, so in that case, your ProFrac operation would represent a quarter-over-quarter decline of roughly 11%?

Bond Clement

executive
#20

Yes, versus the first quarter it's lower by approximately 10%; that is right too.

Richard Dearnley

analyst
#21

So what drove the situation there?

Ryan Ezell

executive
#22

Well, a few factors come into play, and much of this has already been discussed openly in the market. What we're observing is some turbulence in activity levels, where the E&P companies doing deals for pressure pumping work and completions — we've begun noticing what I'd describe as gaps between jobs. In the past, you'd typically see a gap of one to two days, perhaps three days, when moving from one pad to another and so on. These days, many customers are purchasing through the spot market, and we're seeing longer stretches between pads, at times five to seven days. Even though your average fleet count holds roughly steady from one quarter to the next, the level of activity, or pumping days, declined somewhat. Given all that, we'd examine our overall fleet count. We've shifted chemistry across a comparable number of fleets, but once you average out the volume, it dropped a bit, especially in what we observed during May — though we've watched it rebound strongly in July and as we head into August.

Richard Dearnley

analyst
#23

All right, got it. Turning to slide 16, going back to that productivity topic — and I realize this calls for a rough estimate — but what portion of that gain comes from analytics? What portion comes from nanofluids? And what portion comes from all the other pieces?

Ryan Ezell

executive
#24

Good question — it's something we've essentially folded together within our broader strategy. You heard me say that our chemistry has been applied across 20,000 wells. Together with the work our data analytics team performs on that chemistry, we've done considerable machine learning, I'd say, on how our proprietary chemistries get applied across different basins and target zones. We've carried that into conversations with our customers about how we select our chemistry. Even more significant is the way we examine our entire engineering workflow, which we refer to as Prescriptive Chemistry Management, in which we evaluate X-ray diffraction from cuttings and core samples. We examine the produced water and what it's made of. We examine compositional analysis of the crude and hydrocarbons potentially flowing from the reservoir. We also consider other possibilities involving biocide selections, and so on. What we deliver is a holistic, tailored solution — selecting the appropriate friction reducer, clay control, corrosion components, plus the situations where a surfactant-enhanced option applies, which you'd view as either a flowback aid or a Complex nano Fluid. The reason is that sometimes, traditionally, when you examine pure Complex nano Fluid alone, it comes in a bit higher; we take the holistic route on the chemistry management side, and that is where the 26% figure comes from. I'd add that it shifts from well to well, based on formation type and completion design.

Richard Dearnley

analyst
#25

So what you're telling me is that separating out the nano Fluids from the analytics and that sort of thing isn't feasible — it all comes as one large package?

Ryan Ezell

executive
#26

From my perspective, yes, in the sense that we can examine it purely where Complex nano Fluid alone has been used. Those analytics are available to us, but our preference is to take a holistic engineering view covering the complete design of the slickwater system we're applying. That data does exist, and I believe in a few of the more in-depth presentations we'll be giving at certain investor conferences coming up, we'll address specifically how Complex nano Fluid compares against the full engineering and scope design.

Richard Dearnley

analyst
#27

Okay. Thank you.

Ryan Ezell

executive
#28

Mm-hmm.

Don Crist

analyst
#29

Appreciate you having me back on, guys. Ryan, I'd like to touch on JP3. Clearly, you've had a few field tests underway involving the new design. What's the current status there, and is there interest building around broader uptake of JP3?

Ryan Ezell

executive
#30

Yes, Don, that's also a strong question. Like I said earlier, the next-generation model is out in field testing; we have 2 units involved. Results have been outstanding as testing expanded, and we anticipate scaling that business up toward the back half of Q4 and into 2024, when the new units roll out on the production side; that has unlocked... Recently we walked our board through the strategic ways this new technology could be applied in the field, and we're seeing major opportunities in the upstream segment by examining quality, energy content, and BTUs in natural gas. We're looking at flare gas operations, plus power generation broadly, whether that means powering rigs, fracked fleets, electrical turbines, and so on. JP3 has us genuinely enthusiastic. Considering how JP3 and chemistry work in tandem, we see applications not just domestically across North America land, but also major international opportunities involving both the units and, in particular, even offshore for our chemistry. It's truly exciting, the synergy emerging between data and chemistry together, since data means monitoring the actual chemistry at the wellsite.

Don Crist

analyst
#31

All right, that's really thrilling as we move ahead. Bond, let me ask you one additional thing too. Clearly, G&A had a number of shifting pieces this quarter. Do you remain fairly sure you can bring it near that $5 million per quarter run rate, or lower, by the time the year ends?

Bond Clement

executive
#32

Yes, we're putting in the effort; internally, that's what we're aiming for. We simply had a handful of things we brought up here, including some elevated legal expenses. We're attempting to bring this litigation to a close. We managed to eliminate 2 of the 3 components. There's 1 part still remaining; the CEO transition cost is now behind us, so yes. I mean, Don, internally that's what we're aiming for, and that's what we're striving toward.

Don Crist

analyst
#33

I'm eager to see EBITDA turn positive from here on out. I appreciate that, everyone. Nice call. Thank you.

Bond Clement

executive
#34

All right, see you.

Larry Busnardo

executive
#35

Thanks once more for being with us on this call. A quick heads-up: Flotek's Chief Executive Officer, Ryan Ezell, is set to present at 8:50 A.M. Mountain Time next Tuesday, August 15th, at EnerCom Denver, the Energy Investment Conference held in Denver. Alongside him, CFO Bond Clement will take part in investor meetings across the day. Before the presentation begins, a copy of it will go up on the website. At that same conference, Dr. Ezell is also scheduled for a service industry panel discussion on August 16th at 9:50 A.M. Webcasts will cover both events, and we're eager to see plenty of you next week. Once again, thanks for being with us on this call. Should you have any further questions, don't hesitate to reach out to the company. Have a good day.

Operator

operator
#36

That brings us to the end of this call. We appreciate you joining us for today's presentation. You're welcome to disconnect at this time.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.